1. Benet LZ, Sheiner LB (1985) Appendix II. Design and optimization of dosage regimens; pharmacokinetic data. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilmans's. The pharmacological basis of therapeutics. 7th ed. Macmillan, New York, pp 1663?1733
2. Crowley JJ, Cusack BJ, Jue SG, Koup JR, Vestal RE (1986a) Effect of smoking and phenytoin on theophylline metabolism in healthy young adults. Clin Res 34: 90A
3. Crowley JJ, Cusack BJ, Jue SG, Koup JR, Vestal RE (1986b) Induction of theophylline metabolism by phenytoin is unaltered by aging. Clin Res 34: 396A
4. Grasela TH, Sheiner LB, Rambeck B et al. (1983) Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clin Pharmacokinet 8: 355?364
5. Jusko WJ, Koup JR, Alvan G (1976) Nonlinear assessment of phenytoin bioavailability. J Pharmacokinet Biopharm 4: 327?336